跳至主要内容
临床试验/NL-OMON36874
NL-OMON36874撤回不适用

To study the effects of anti fungal treatment of a subset in CLL patients harboring stereotypic receptors with high specificity for yeasts and molds. - posaconazole Study

Academisch Medisch Centrum0 个研究点目标入组 3 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Diagnosis of CLL / MBL with mutated IGHV3-7 rearrangements paired to IGKV2-24 encoded light chains;
  • * Age 18-80 years
  • * No CLL related treatment during the last 3 months;
  • * Able to adhere to the study visit schedule and other protocol requirements;
  • * WHO performance status of * 2;
  • * Laboratory test results within these ranges: absolute neutrophil count * 1.0 x 109/l, platelet count * 30 x 109/l, creatinine clearance * 60 ml/min, total bilirubin * 25 µmol/L, AST & ALT * 2 x ULN;
  • * Written informed consent.

排除标准

  • * Known hypersensitivity and/or serious adverse reactions to posaconazole or similar drugs
  • * Concomitant anti-yeast/mould medication;

研究者

相似试验